Clinical efficacy and molecular response correlates of the WEE1 inhibitor adavosertib combined with cisplatin in patients with metastatic triple-negative breast cancer (mTNBC)
暂无分享，去创建一个
P. Sorger | E. Winer | G. Shapiro | B. Overmoyer | A. D’Andrea | E. Allen | R. Pastorello | S. Tolaney | M. X. He | T. Vallius | B. Kochupurakkal | Jennifer L. Guerriero | J. Conway | T. Keenan | L. Anderson | Tianyu Li | R. Godin | Erin Shannon | R. Tahara | Janae Davis | Nabihah | Tayob | A. Elizabeth | Mittendorf